Last reviewed · How we verify

NCT03565822: INEMAT

The Impact of the Birth of a Child With a Rare Abdomino-thoracic Malformation

Completed NA Last updated 2 October 2019
What this trial tests

NA trial testing Interview in Congenital Malformation in 30 participants. Completed in 15 July 2019.

Timeline
15 December 2017
Primary endpoint
15 July 2019
15 July 2019

Quick facts

Lead sponsorUniversity Hospital, Lille
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment30
Start date15 December 2017
Primary completion15 July 2019
Estimated completion15 July 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Lille

Who can join

18 and older, any sex, with Congenital Malformation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Qualitative study in psychology whose main objective is to propose a grounded theory to report the dynamics of parental adjustment for the period from the announcement of the diagnosis to one year of the child affected by a rare thoracic abdominal congenital malformation, requiring neonatal surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Interview

Trials testing the same drug.

Other recruiting trials for Congenital Malformation

Currently open trials in the same condition.

Other University Hospital, Lille trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03565822.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing